These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30660694)
1. Efficacy of a novel LyP-1-containing self-microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer. Timur SS; Yöyen-Ermiş D; Esendağlı G; Yonat S; Horzum U; Esendağlı G; Gürsoy RN Eur J Pharm Biopharm; 2019 Mar; 136():138-146. PubMed ID: 30660694 [TBL] [Abstract][Full Text] [Related]
2. Design, characterization and in vitro evaluation of SMEDDS containing an anticancer peptide, linear LyP-1. Gürsoy RN; Çevik Ö Pharm Dev Technol; 2014 Jun; 19(4):486-90. PubMed ID: 23678858 [TBL] [Abstract][Full Text] [Related]
3. Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer. Timur SS; Bhattarai P; Gürsoy RN; Vural İ; Khaw BA Pharm Res; 2017 Feb; 34(2):352-364. PubMed ID: 27896591 [TBL] [Abstract][Full Text] [Related]
4. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer. Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597 [TBL] [Abstract][Full Text] [Related]
5. LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics. Wang Z; Yu Y; Ma J; Zhang H; Zhang H; Wang X; Wang J; Zhang X; Zhang Q Mol Pharm; 2012 Sep; 9(9):2646-57. PubMed ID: 22853186 [TBL] [Abstract][Full Text] [Related]
6. Novel Drug Delivery Approach via Self-Microemulsifying Drug Delivery System for Enhancing Oral Bioavailability of Asenapine Maleate: Optimization, Characterization, Cell Uptake, and In Vivo Pharmacokinetic Studies. Patel MH; Mundada VP; Sawant KK AAPS PharmSciTech; 2019 Jan; 20(2):44. PubMed ID: 30617712 [TBL] [Abstract][Full Text] [Related]
7. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor. Yan Z; Wang F; Wen Z; Zhan C; Feng L; Liu Y; Wei X; Xie C; Lu W J Control Release; 2012 Jan; 157(1):118-25. PubMed ID: 21827801 [TBL] [Abstract][Full Text] [Related]
8. Structure Reconstruction of LyP-1: Zhang X; Wang F; Shen Q; Xie C; Liu Y; Pan J; Lu W Mol Pharm; 2018 Feb; 15(2):430-436. PubMed ID: 29215294 [TBL] [Abstract][Full Text] [Related]
9. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Kang BK; Lee JS; Chon SK; Jeong SY; Yuk SH; Khang G; Lee HB; Cho SH Int J Pharm; 2004 Apr; 274(1-2):65-73. PubMed ID: 15072783 [TBL] [Abstract][Full Text] [Related]
10. LyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphatics. Yan Z; Zhan C; Wen Z; Feng L; Wang F; Liu Y; Yang X; Dong Q; Liu M; Lu W Nanotechnology; 2011 Oct; 22(41):415103. PubMed ID: 21914940 [TBL] [Abstract][Full Text] [Related]
11. Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide. Li C; Wang Y; Zhang X; Deng L; Zhang Y; Chen Z Int J Nanomedicine; 2013; 8():1051-62. PubMed ID: 23515368 [TBL] [Abstract][Full Text] [Related]
12. Design and development of SMEDDS for colon-specific drug delivery. Bansode ST; Kshirsagar SJ; Madgulkar AR; Bhalekar MR; Bandivadekar MM Drug Dev Ind Pharm; 2016; 42(4):611-23. PubMed ID: 26146768 [TBL] [Abstract][Full Text] [Related]
13. Hybrid curcumin-phospholipid complex-near-infrared dye oral drug delivery system to inhibit lung metastasis of breast cancer. Liu Y; Huang P; Hou X; Yan F; Jiang Z; Shi J; Xie X; Shen J; Fan Q; Wang Z; Feng N Int J Nanomedicine; 2019; 14():3311-3330. PubMed ID: 31190795 [No Abstract] [Full Text] [Related]
14. The enhanced inhibitory effect of different antitumor agents in self-microemulsifying drug delivery systems on human cervical cancer HeLa cells. Ujhelyi Z; Kalantari A; Vecsernyés M; Róka E; Fenyvesi F; Póka R; Kozma B; Bácskay I Molecules; 2015 Jul; 20(7):13226-39. PubMed ID: 26197311 [TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of self-microemulsifying liquid and granule formulations of Brucea javanica oil. Shao A; Chen G; Jiang N; Li Y; Zhang X; Wen L; Yang F; Wei S Arch Pharm Res; 2013 Aug; 36(8):993-1003. PubMed ID: 23595551 [TBL] [Abstract][Full Text] [Related]
16. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. Luo G; Yu X; Jin C; Yang F; Fu D; Long J; Xu J; Zhan C; Lu W Int J Pharm; 2010 Jan; 385(1-2):150-6. PubMed ID: 19825404 [TBL] [Abstract][Full Text] [Related]
17. Enhanced oral bioavailability of felodipine by novel solid self-microemulsifying tablets. Jing B; Wang Z; Yang R; Zheng X; Zhao J; Tang S; He Z Drug Dev Ind Pharm; 2016; 42(3):506-12. PubMed ID: 26177197 [TBL] [Abstract][Full Text] [Related]
18. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems. Wang Y; Sun J; Zhang T; Liu H; He F; He Z Drug Dev Ind Pharm; 2011 Oct; 37(10):1225-30. PubMed ID: 21615281 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of a self-microemulsifying drug delivery system of tacrolimus. von Suesskind-Schwendi M; Gruber M; Touraud D; Kunz W; Schmid C; Hirt SW; Lehle K Biomed Pharmacother; 2013 Jul; 67(6):469-73. PubMed ID: 23669280 [TBL] [Abstract][Full Text] [Related]
20. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy. Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]